After being fired, I became the light of medicine

Chapter 53 ITG Human Myelopoietin Price? !

"Su Province First People's Hospital, 25000 boxes, a total of 1200 million yuan."

"Shanghai Jiaotong University Ruijin Hospital, 30000 boxes, a total of 1440 million yuan."

"Sichuan West China Hospital...50000 boxes, totaling 2400 million yuan!"

"..."

"Zhang Yang, I have to say that these big hospitals are really well-off. They can buy tens of millions of dollars without any hesitation."

Looking at the purchase order in his hand, Ren Xiaomin was filled with emotion.

In the past few months, he has traveled to all the major tertiary hospitals in the surrounding area, but the purchase volume he finally negotiated for in-hospital purchases is not even as much as that of West China Hospital alone.

Zhang Yang didn't feel anything. This was the current medical situation in the country. The scale of top hospitals like West China Hospital was simply incomparable to that of ordinary tertiary hospitals.

"By the way, have they agreed to our payment method?"

"They agreed. They were very straightforward."

Ren Xiaomin smiled and nodded.

According to the conventions of the pharmaceutical industry, pharmaceutical companies have to wait at least half a year after supplying goods to hospitals before they can get paid. However, this time Zhang Yang directly asked the hospital to pay at least 50% first, and then pay the remaining balance three months later.

Zhang Yang also smiled. He knew very well that the reason why the hospital was so straightforward was because of "ITG human myelopoietin".

"Okay, Brother Ren, I'll leave the rest to you."

"However, although we are in an active position now, with the entry of Qingshan Afa into the hospital, the annual procurement volume is expected to be large, so we still have to maintain a good relationship with them."

"Don't worry, I know!"

"Ok!"

After solving the problem of Qingshan Avatrombopag entering the hospital, Qingshan Pharmaceutical's current predicament has been perfectly resolved.

The next day, as several hospitals transferred tens of millions of dollars in drug purchase funds, Zhang Yang's attention fell on the hepatitis B drug "Abrofovir".

The clinical trial of "Abrocitinib" was temporarily shelved before. On the one hand, it was because it was too close to "ITG estrogen hormone", and it was too abrupt and difficult to explain to suddenly come up with a new drug.

On the other hand, it was also because Qingshan Pharmaceutical was short of funds at the time, and it cost money to expand its R&D staff and conduct the third phase of the "ITG" clinical trial.

At least the funding issue is resolved now.

but……

After thinking for a long time, Zhang Yang still couldn't think of a more appropriate way to start the clinical trial of "Acofenprofovir".

Last time, “ITG human myelopoietin” was used as an adjuvant therapy and then turned into a first-line drug. It certainly cannot be used again this time.

After thinking it over, the only solution is to wait!

"Alas! We can only wait a little longer until 'ITG Myelopoietin' is on the market for a while!"

Having made up his mind, Zhang Yang seemed a little helpless.
I had no choice but to put the matter of "Acofenprofovir" aside for the time being and start fully preparing for the launch of "ITG Human Myelopoietin"!

One month later, the last group of the Phase III clinical trial of "ITG Human Myelopoietin" completed the clinical trial, which also means that the Phase III clinical trial of "ITG Myelopoietin" has been completed!
The clinical data this time was no different from the previous group. All patients in the "experimental group" were completely cured by bone marrow biopsy, while those in the control group, although their blood counts were good due to taking "Avatrombopag Tablets", still suffered from "aplastic anemia" according to bone marrow biopsy results.

550 complete sets of data were quickly submitted to the State Food and Drug Administration. Because "ITG" is a drug for treating blood diseases like "Qingshan Afa" at the beginning, the approval process still went through the green channel specially opened by the state.

In just one and a half months, "ITG Human Myelopoietin" passed the Phase III clinical trial without any controversy due to its excellent therapeutic effect. Zhang Yang immediately began to apply for drug production approval.

"ITG Human Myelopoietin" still chose to be produced by Lotus Pharmaceuticals, which has always been the OEM for "Qingshan Afa".

However, this time the production difficulty of "ITG" was obviously higher and the requirements were stricter. It took Lotus Pharmaceuticals more than a month to meet various production indicators and achieve drug production standards.

A week later,

The drug production approval was successfully passed, and the relevant parameter information of Tsingshan Pharmaceutical's "ITG Human Myelopoietin" appeared on the official website of the State Food and Drug Administration for the first time!

So far,

All the procedures before "ITG" is put on the market have been completed, which also means that "ITG myelopoietin", which can completely cure "aplastic anemia", has entered the countdown to its market launch!
Countless patients who have been paying attention to "ITG estrogen" cheered and rejoiced, finally waiting for this day!

Those patients who came here for the treatment, waited for a long time, or even delayed their "bone marrow transplant" excitedly rushed to the website of the State Food and Drug Administration to check out the relevant information about "ITG human myelopoietin" in advance.

The China Pharmaceutical News soon noticed this matter and immediately compiled all the data and information of Tsingshan Pharmaceutical's "ITG Human Myelogenin" into an article and published it on its official account.

"Quick, Huaxia Medicine's official account has published an article about 'ITG epoxin'. Let's take a look at what it looks like and how to use it!"

After a while, many patients in the group opened the official account article and started reading.

[Unlike the previous "Qingshan Avatrombopag", "ITG epoxin" is an injectable preparation, a colorless clear liquid, and is mainly injected intravenously. ]

[At the same time, because the main ingredient is active recombinant oepithecin, it needs to be refrigerated at low temperature. If it is kept at room temperature for two hours, the drug activity will decrease and lose its efficacy. ]

Seeing this, no one cared that "ITG" was an injectable preparation.

After all, almost every patient with aplastic anemia is a frequent visitor to the hospital, and it is normal to go to the hospital for injections.

Soon, everyone saw the information on dosage and medication cycle.

[The total ITG treatment cycle is three months, twelve weeks. ]

[After patients start ITG treatment, they only need to take a drug injection once a week for 12 consecutive weeks. ]

[According to clinical trial data, 86% of patients with common aplastic anemia were cured after eight weeks of continuous treatment, and the remaining 14% were completely cured at the tenth week.]

[After ten weeks of continuous treatment, 78% of the "super severe aplastic anemia patients" were cured, and the remaining 22% were completely cured after twelve weeks.]

[Please note that 0.2% of patients are still not completely cured after twelve weeks, and this situation requires another consolidation cycle. ]

Although many patients already knew from previous clinical trial subjects that the cure rate of "ITG" is almost 100%, they were truly relieved when they saw the official data with their own eyes.

One injection per week, and you can be completely cured in just two or three months. This method is completely acceptable!
Everyone continued to watch and soon saw the adverse reactions.

[Common adverse reactions during treatment with this product include: nausea, vomiting, diarrhea, loss of appetite, drowsiness...]

[Rare adverse reactions during treatment with this product include: hair loss, insomnia, irritability, anxiety, etc. ……]

After reading to the end, everyone finally felt relieved and had a clearer understanding of "ITG human myelopoietin"...

But gradually, as the excitement wore off, everyone started to feel more nervous.

According to the "ITG" own instructions, most patients can actually be completely cured with eight injections in two months. So how much does this injection cost? !

Speculations and discussions about the price of "ITG" have gradually emerged in major patient groups.

(End of this chapter)